BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23297334)

  • 1. Primary colorectal cancer: use of kinetic modeling of dynamic contrast-enhanced CT data to predict clinical outcome.
    Koh TS; Ng QS; Thng CH; Kwek JW; Kozarski R; Goh V
    Radiology; 2013 Apr; 267(1):145-54. PubMed ID: 23297334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival.
    Ng F; Ganeshan B; Kozarski R; Miles KA; Goh V
    Radiology; 2013 Jan; 266(1):177-84. PubMed ID: 23151829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic contrast-enhanced CT of head and neck tumors: perfusion measurements using a distributed-parameter tracer kinetic model. Initial results and comparison with deconvolution-based analysis.
    Bisdas S; Konstantinou GN; Lee PS; Thng CH; Wagenblast J; Baghi M; Koh TS
    Phys Med Biol; 2007 Oct; 52(20):6181-96. PubMed ID: 17921579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic Contrast-Enhanced MRI Kinetic Parameters as Prognostic Biomarkers for Prediction of Survival of Patient with Advanced Hepatocellular Carcinoma: A Pilot Comparative Study.
    Lee SH; Hayano K; Zhu AX; Sahani DV; Yoshida H
    Acad Radiol; 2015 Nov; 22(11):1344-60. PubMed ID: 26211553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tracer kinetics analysis of dynamic contrast-enhanced CT and MR data in patients with squamous cell carcinoma of the upper aerodigestive tract: comparison of the results.
    Bisdas S; Baghi M; Wagenblast J; Bisdas T; Thng CH; Mack MG; Koh TS; Ernemann U
    Clin Physiol Funct Imaging; 2009 Sep; 29(5):339-46. PubMed ID: 19473200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumoral and nontumoral pancreas: correlation between quantitative dynamic contrast-enhanced MR imaging and histopathologic parameters.
    Bali MA; Metens T; Denolin V; Delhaye M; Demetter P; Closset J; Matos C
    Radiology; 2011 Nov; 261(2):456-66. PubMed ID: 21852570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-input tracer kinetic modeling of dynamic contrast-enhanced MRI in thoracic malignancies.
    Lee SH; Rimner A; Deasy JO; Hunt MA; Tyagi N
    J Appl Clin Med Phys; 2019 Nov; 20(11):169-188. PubMed ID: 31602789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping the zonal organization of tumor perfusion and permeability in a rat glioma model by using dynamic contrast-enhanced synchrotron radiation CT.
    Balvay D; Troprès I; Billet R; Joubert A; Péoc'h M; Cuenod CA; Le Duc G
    Radiology; 2009 Mar; 250(3):692-702. PubMed ID: 19095783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal tumor vascularity: quantitative assessment with multidetector CT--do tumor perfusion measurements reflect angiogenesis?
    Goh V; Halligan S; Daley F; Wellsted DM; Guenther T; Bartram CI
    Radiology; 2008 Nov; 249(2):510-7. PubMed ID: 18812560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Water-Exchange-Modified Kinetic Parameters from Dynamic Contrast-Enhanced MRI as Prognostic Biomarkers of Survival in Advanced Hepatocellular Carcinoma Treated with Antiangiogenic Monotherapy.
    Lee SH; Hayano K; Zhu AX; Sahani DV; Yoshida H
    PLoS One; 2015; 10(9):e0136725. PubMed ID: 26366997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic contrast-enhanced CT of intracranial meningioma: comparison of distributed and compartmental tracer kinetic models--initial results.
    Dennis Cheong LH; Tchoyoson Lim CC; Koh TS
    Radiology; 2004 Sep; 232(3):921-30. PubMed ID: 15247436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tracer kinetic model selection for dynamic contrast-enhanced computed tomography imaging of prostate cancer.
    Korporaal JG; van Vulpen M; van den Berg CA; van der Heide UA
    Invest Radiol; 2012 Jan; 47(1):41-8. PubMed ID: 21610505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of dynamic contrast-enhanced MR imaging to predict survival in patients with primary breast cancer undergoing neoadjuvant chemotherapy.
    Li SP; Makris A; Beresford MJ; Taylor NJ; Ah-See ML; Stirling JJ; d'Arcy JA; Collins DJ; Kozarski R; Padhani AR
    Radiology; 2011 Jul; 260(1):68-78. PubMed ID: 21502383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced Hepatocellular Carcinoma: Perfusion Computed Tomography-Based Kinetic Parameter as a Prognostic Biomarker for Prediction of Patient Survival.
    Lee SH; Hayano K; Zhu AX; Sahani DV; Yoshida H
    J Comput Assist Tomogr; 2015; 39(5):687-96. PubMed ID: 26222909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiphasic contrast injection for improved precision of parameter estimates in functional CT.
    Kim SM; Cho YB; Haider MA; Milosevic M; Yeung IW
    Med Phys; 2008 Dec; 35(12):5921-33. PubMed ID: 19175147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadolinium-enhanced echo-planar T2-weighted MRI of tumors in the extracranial head and neck: feasibility study and preliminary results using a distributed-parameter tracer kinetic analysis.
    Bisdas S; Baghi M; Wagenblast J; Vogl TJ; Thng CH; Koh TS
    J Magn Reson Imaging; 2008 May; 27(5):963-9. PubMed ID: 18407543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intravenous contrast agent volume on colorectal cancer vascular parameters as measured by perfusion computed tomography.
    Goh V; Bartram C; Halligan S
    Clin Radiol; 2009 Apr; 64(4):368-72. PubMed ID: 19264180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic contrast-enhanced CT of head and neck tumors: comparison of first-pass and permeability perfusion measurements using two different commercially available tracer kinetics models.
    Bisdas S; Konstantinou G; Surlan-Popovic K; Khoshneviszadeh A; Baghi M; Vogl TJ; Koh TS; Mack MG
    Acad Radiol; 2008 Dec; 15(12):1580-9. PubMed ID: 19000875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variations of quantitative perfusion measurement on dynamic contrast enhanced CT for colorectal cancer: implication of standardized image protocol.
    Niu T; Yang P; Sun X; Mao T; Xu L; Yue N; Kuang Y; Shi L; Nie K
    Phys Med Biol; 2018 Aug; 63(16):165009. PubMed ID: 29889046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method for patient dose reduction in dynamic contrast enhanced CT study.
    Kim SM; Haider MA; Milosevic M; Jaffray DA; Yeung IW
    Med Phys; 2011 Sep; 38(9):5094-103. PubMed ID: 21978055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.